Nextage Therapeutics (XTAE:NXTG) FCF Margin % : -44.60% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nextage Therapeutics's Free Cash Flow for the six months ended in Dec. 2023 was ₪-0.32 Mil. Nextage Therapeutics's Revenue for the six months ended in Dec. 2023 was ₪0.71 Mil. Therefore, Nextage Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -44.60%.

As of today, Nextage Therapeutics's current FCF Yield % is -8.15%.

The historical rank and industry rank for Nextage Therapeutics's FCF Margin % or its related term are showing as below:

XTAE:NXTG' s FCF Margin % Range Over the Past 10 Years
Min: -25092.86 Med: -2356.19 Max: -258.22
Current: -258.22

During the past 8 years, the highest FCF Margin % of Nextage Therapeutics was -258.22%. The lowest was -25092.86%. And the median was -2356.19%.

XTAE:NXTG's FCF Margin % is ranked worse than
92.4% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs XTAE:NXTG: -258.22

Nextage Therapeutics FCF Margin % Historical Data

The historical data trend for Nextage Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics FCF Margin % Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-680.80

-3,309.42

-4,367.03

-258.22

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial									3,163.27	-	-	-1,192.64	-44.60

Competitive Comparison of Nextage Therapeutics's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Nextage Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nextage Therapeutics's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nextage Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nextage Therapeutics's FCF Margin % falls into.

Nextage Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nextage Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2.262	/	0.876
	=	-258.22 %

Nextage Therapeutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.318	/	0.713
	=	-44.60 %

Nextage Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021